Protective effect of a poly-phytocompound on early stage nephropathy secondary to experimentally-induced diabetes

Journal of Biological Regulators and Homeostatic Agents

Volumn 24, Issue 1, 2010, Pages 41-49

  Marotta, F ^a   Harada, M ^b   Dallah, E D ^b   Yadav, H ^c   Solimene, U ^a   Lembo, S D I ^d   Minelli, E ^a   Jain, S ^e   Chui, D H ^f  

^a UNIVERSITY OF MILAN   (Italy)

^b MHC Hospital   (Japan)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d S Giuseppe Hospital   (Italy)

^e UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^f PEKING UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; DTS; Oxidative stress

Indexed keywords

ALBUMIN; COMPLEMENTARY DNA; EUCOMMIA ULMOIDES EXTRACT; GLUCOSE; LIPID; MALONALDEHYDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEPHRIN; RNA; STREPTOZOCIN; CCL2 PROTEIN, RAT; MEMBRANE PROTEIN; PRIMER DNA;

ALBUMIN BLOOD LEVEL; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; BLOOD SAMPLING; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE SEVERITY; DNA SYNTHESIS; DRUG EFFECT; DRUG EFFICACY; EXPERIMENTAL DIABETES MELLITUS; FLUORESCENCE ANALYSIS; GENE EXPRESSION; GLOMERULOSCLEROSIS; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; KIDNEY; KIDNEY FIBROSIS; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEINURIA; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REDOX STRESS; RENAL PROTECTION; RNA EXTRACTION; TREATMENT DURATION; URINALYSIS; ANIMAL; FEMALE; GENETICS; GINSENG; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYTOTHERAPY; WISTAR RAT;

ANIMALIA; EUCOMMIA ULMOIDES; PANAX PSEUDOGINSENG; RATTUS; RATTUS NORVEGICUS;

ANIMALS; BASE SEQUENCE; BLOOD GLUCOSE; CHEMOKINE CCL2; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DNA PRIMERS; FEMALE; LIPID PEROXIDATION; MALE; MEMBRANE PROTEINS; OXIDATIVE STRESS; PANAX; PHYTOTHERAPY; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 77953704219     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Adeghate E. Diabetes mellitus-multifactorial in aetiology and global in prevalence. Arch Physiol. Biochem 2001; 109:197-9. (Pubitemid 35216686)
2. Harris MI, Flegal KM, Cowie CC. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998; 21:518-24.
3. Ruiz C, Alegria A, Barbera R, Faire R, Lagarda MJ. Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus. Scand J Clin Lab Invest 1994; 59:99-105.
4. Koya D, Hayashi K, Kitada M, et al. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol 2003; 14:250-53.
5. Ha H, Kim KH. Role of oxidative stress in the development of diabetic nephropathy. Kidney Int 1995; 48(S):18-21.
6. Beisswenger PJ, Drummond KS, Nelson RG, et al. Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. Diabetes 2005; 54: 3274-81.
7. Chang JM, Kuo MC, Kuo HT, et al. Increased glomerular and extracellular malondialdehyde levels in patients and rats with diabetic nephropathy. J Lab Clin Med 2005; 146:210-15.
8. Lee HB, Cha MK, Song KI, Kim JH, Lee EY, Kim SI, Kim J, Yao MH. Pathogenic role of advanced glycosylation end products in diabetic nephropathy. Kidney Int 1997; 52(S):60-65.
9. Makino H, Shikata K, Kaushiro M, Hironaka K, Yamasaki Y, Sagimato H, Ota Z, Araki N, Hariuchi S. Roles of advanced glycation end-products in the progression of diabetic nephropathy. Nephrol Dial Transplant 1996; 11(S):76-80.
10. The Diabetes Control and Complications Trial Group: The effect of intensive insulin treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-86.
11. Dahl-Jorgensen D, Bjoro T, Kierulf P, Sandivik KL, Bangstad HI, Hansen K. Long term glycemic control and kidney function in insulin-independent diabetes mellitus. Kidney Int 1992; 41:920-23.
12. Broch-Johnsen K, Anderson PK, Deckert T. The effect of proteinuria on relative mortality in Type I (insulin-dependent) diabetes mellitus. Diabetologia 1985; 14:369-79.
13. Doublier S, Salvidio G, Lupia E, Ruotsalainen V, Verzola D, Deferrari G. Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 2003; 52:1023-30.
14. Marotta F, Lorenzetti F, Harada M, Ono-Nita SK, Minelli E, Marandola P. Redox status impairment in liver and kidney of prematurely senescent mice: effectiveness of DTS phytotherapeutic compound. Ann NY Acad Sci 2006; 1067:408-13.
15. Marotta F, Harada M, Minelli E, Ono-Nita SK, Marandola P. "Accelerating aging" chemotherapy on aged animals: protective effect from nutraceutical modulation. Rejuvenation Res 2008; 11:513-17.
16. Marotta F, Yadav H, Gumaste U, Helmy A, Jain S, Minelli E. Protective effect of a phytocompound on oxsidative stress and DNA fragmentation against paracetamol-induced liver damage. Ann Hepatol 2009; 8:50-56.
17. Fossati P, Prencipe L, Berti G. Enzymic creatinine assay: a new colorimetric method based on hydrogen peroxide measurement. Clin Chem 1983; 29:1494-96.
18. Liang AH, Huang YJ, Jiang ZL. A rapid and sensitive immunoresonance scattering spectral assay for microalbumin. Clin Chim Acta 2007; 383:73-77.
19. Flohé L, Gunzle WA. Assays of glutathione peroxidase. Methods Enzymol 1984; 105:114-21.
20. Aebi H. Catalase. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. New York: Chemic Academic Press 1974: 673-85.
21. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95:351-58.
22. Bradford MM. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein dye binding. Anal Biochem 1976; 72:248-54.
23. Wang SX, Mené P, Holthöfer H. Nephrin mRNA regulation by protein kinase C. J Nephrol 2001; 14: 98-103.
24. Scandling JD, Myers BD. Glomerular size selectivity and microalbuminuria in early diabetic glomerular disease. Kidney Int 1992; 41:840-46.
25. Ditzel J, Schwartz M. Abnormally increased glomerular filtration rate in short-term insulin-treated diabetic subjects. Diabetes 1967; 16:264-67.
26. Hostetter TH. Diabetic nephropathy: metabolic versus hemodynamic considerations. Diabetes Care 1992; 15:1205-15.
27. Taguma Y, Kitamoto Y, Futaki G. Effect of Captopril on heavy proteinuria in azotemic diabetics. N Engl J Med 1985; 313:1617-20.
28. Marcantoni C, Ortalda V, Lupo A, Maschio G. Progression of renal failure in diabetic nephropathy. Nephrol Dial Transplant 1998; 13(S)8:16-19.
29. Liu S, Shi L, Wang S. Overexpression of upstream stimulatory factor 2 accelerates diabetic kidney injury. Am J Physiol Renal Physiol 2007; 293: F1727-35.
30. Iglesias-de la Cruz MC, Ziyadeh FN, Isono M, Kouahou M, Han DC, Kalluri R. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. Kidney Int 2002; 62:901-13.
31. Durvasula RV, Shankland SJ. Podocyte injury and targeting therapy: an update. Curr Opin Nephrol Hypertens 2006; 15:1-7. (Pubitemid 43755826)
32. Forbes JM, Bonnet F, Russo LM, et al. Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria. J Hypertens 2002; 20:985-92,.
33. Toyoda M, Suzuki D, Umezonz T, Uehara G, Maruyama M, Honma M. Expression of human nephrin mRNA in diabetic nephropathy. Nephrol Dial Transplant 2004; 19:380-85.
34. Jin X, Otonashi-Satoh Y, Sun P, Kawamura N, Tsuboi T, Yamaguchi Y, Ueda T, Kawasaki H. Endothelium-derived Hyperpolarizing Factor (EDHF) Mediates Endothelium-dependent vasodilator Effects of Aqueous Extracts from Eucommia ulmoides Oliv. Leaves in Rat Mesenteric Resistance Arteries. Acta Med Okayama 2008; 62:319-25.